Related references
Note: Only part of the references are listed.Close Margins Less Than 2 mm Are Not Associated With Higher Risks of 10-Year Local Recurrence and Breast Cancer Mortality Compared With Negative Margins in Women Treated With Breast-Conserving Therapy
Susan Tyler et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
J. A. Alberro et al.
LANCET ONCOLOGY (2018)
Margins in Breast-Conserving Surgery After Neoadjuvant Therapy
Jungeun Choi et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy
Marco Galvez et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2018)
Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017)
Michael Untch et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2017)
HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma
Yanjun Hou et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases
T. J. A. van Nijnatten et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Evaluation of Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Experience in a Single Institution over a 10-Year Period
Misun Choi et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2017)
Neoadjuvant chemotherapy in breast-conserving surgery - Consequences on margin status and excision volumes: A nationwide pathology study
J. H. Volders et al.
EJSO (2016)
Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment
Eunjin Jwa et al.
CANCER RESEARCH AND TREATMENT (2016)
Breast Cancer Version 2.2015
William J. Gradishar et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
The Association of Surgical Margins and Local Recurrence in Women with Early-Stage Invasive Breast Cancer Treated with Breast-Conserving Therapy: A Meta-Analysis
Nehmat Houssami et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer
Meena S. Moran et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Shrink pattern of breast cancer after neoadjuvant chemotherapy and its correlation with clinical pathological factors
Shushu Wang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Gunter von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL-CALGB 150007/150012, ACRIN 6657
Laura J. Esserman et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Surgical Margins in Lumpectomy for Breast Cancer - Bigger Is Not Better
Monica Morrow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort study
F. Fitzal et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Locoregional Treatment of Primary Breast Cancer Consensus Recommendations From an International Expert Panel
Manfred Kaufmann et al.
CANCER (2010)
Intraoperative frozen section analysis for breast-conserving therapy in 1016 patients with breast cancer
O. Riedl et al.
EJSO (2009)
Preoperative therapy in invasive breast cancer: Pathologic assessment and systemic therapy issues in operable disease
Julie R. Gralow et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome
Chafika Mazouni et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcome
Oreste Gentilini et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
Share Paper
